A substantial amount of recent research highlighted the importance of the inflammatory syndrome in schizophrenia. Markers of inflammation mentioned as elevated in the blood of schizophrenic patients are interleukin 6, C-reactive protein and tumor necrosis factor-α Recent studies are focused on the benefit of addon therapy with anti-inflammatory agents in the cases which do not reach complete recovery following conventional antipsychotic therapy. The main goal is to initiate pharmacological treatment during the early phases of the disease, in order to improve the course and the prognosis of the disease.
📖 افتح في inklap 🔗 DOI 📮 اطلب بحثاً